HALEY TILLMAN: Open Payments
NPI 1225787740 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 21 payments from 7 companies in 2025. Trend: 2023 $333 · 2024 $374 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $219 |
| E.R. Squibb & Sons, L.L.C. | 10 | $140 |
| Merck Sharp & Dohme LLC | 5 | $119 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $31 |
| Amgen Inc. | 1 | $20 |
| ABIOMED | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: PASCAL, CAMZYOS, VERQUVO, LifeVest, REPATHA, LEQVIO, ELIQUIS.
Industry payments across MS — which companies pay providers there.
